PV
Polaris Venture Management Co. V, L.L.C.
Concentrated strategyLong-term holderQuality / disciplined sizing
Total reported value
$14.1M
Reporting period: 2021-09-30 · Number of holdings: 6
Polaris Venture Management Co. V, L.L.C. disclosed 6 holdings in its latest 13F filing for the period ending 2021-09-30, with total reported value of $14.1M and a quarterly turnover rate of 0.0%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 12
- Sizing Uniformity
- 83.79
Recent moves
No holding changes this quarter
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LYRAGBP | Lyra Therapeutics INC | Stock-Other | 71.28% | — | — | |
| 2 | ✓ | X4 Pharmaceuticals, Inc. | Stock-Other | 11.70% | — | — | |
| 3 | LIFEUSD | Atyr Pharma INC | Stock-Other | 8.42% | — | — | |
| 4 | CERUEUR | Dare Bioscience INC | Stock-Other | 3.87% | — | — | |
| 5 | GNCAQ | Genocea Biosciences INC | Stock-Other | 2.69% | — | — | |
| 6 | PULMEUR | Pulmatrix INC | Stock-Other | 2.04% | — | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2021-09-30 | 6 | $14.1M | 0 | |
| 2021-06-30 | 7 | $62.4M | 100 | |
| 2021-03-31 | 8 | $77.1M | 13 | |
| 2020-12-31 | 8 | $76.6M | 34 | |
| 2020-09-30 | 9 | $60.7M | 76 | |
| 2020-06-30 | 10 | $128.5M | 32 | |
| 2020-03-31 | 10 | $110.5M | 31 | |
| 2019-12-31 | 11 | $137.5M | 33 | |
| 2019-09-30 | 11 | $176.0M | 82 | |
| 2019-06-30 | 12 | $127.3M | 28 | |
| 2019-03-31 | 12 | $118.2M | 42 | |
| 2018-12-31 | 12 | $93.7M | 74 | |
| 2018-09-30 | 12 | $199.7M | 21 | |
| 2018-06-30 | 12 | $183.5M | 53 | |
| 2018-03-31 | 11 | $175.4M | 56 | |
| 2017-12-31 | 10 | $113.4M | 53 | |
| 2017-09-30 | 9 | $116.3M | 78 | |
| 2017-06-30 | 8 | $96.6M | 44 | |
| 2017-03-31 | 9 | $93.4M | 40 | |
| 2016-12-31 | 9 | $84.2M | 24 | |
| 2016-09-30 | 9 | $94.7M | 17 | |
| 2016-06-30 | 10 | $93.2M | 66 | |
| 2016-03-31 | 9 | $104.7M | 29 | 189532E289853L3372427 |
| 2015-12-31 | 9 | $127.3M | 21 | |
| 2015-09-30 | 9 | $146.8M | 46 | |
| 2015-06-30 | 9 | $224.2M | 67 | |
| 2015-03-31 | 7 | $223.8M | 66 | |
| 2014-12-31 | 6 | $126.4M | 17 | 189853L289532E315708Q |
| 2014-09-30 | 6 | $129.6M | 67 | 189853L289532E3372427 |
| 2014-06-30 | 5 | $122.7M | 35 | 1372427205548N389532E |
| 2014-03-31 | 6 | $120.4M | 0 | 1372427289532E305548N |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
FAQ
What is Polaris Venture Management Co. V, L.L.C. and what type of investor is it?
Polaris Venture Management Co. V, L.L.C. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2021-09-30), the firm manages a tracked equity portfolio valued at approximately $14.1M, spread across 6 disclosed positions.
What are Polaris Venture Management Co. V, L.L.C.'s largest equity positions?
Based on the latest 13F filing, Polaris Venture Management Co. V, L.L.C.'s top holdings by market value are:
1. Lyra Therapeutics INC (LYRAGBP) — $10.0M (71.3%)
2. X4 Pharmaceuticals, Inc. — $1.6M (11.7%)
3. Atyr Pharma INC (LIFEUSD) — $1.2M (8.4%)
4. Dare Bioscience INC (CERUEUR) — $545.0K (3.9%)
5. Genocea Biosciences INC (GNCAQ) — $379.0K (2.7%)
What changes did Polaris Venture Management Co. V, L.L.C. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Polaris Venture Management Co. V, L.L.C. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Polaris Venture Management Co. V, L.L.C. focus on?
Sector breakdown data is not yet available for Polaris Venture Management Co. V, L.L.C.. Check back after the next 13F processing cycle.